VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 165 filers reported holding VANDA PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is 0.33 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $7,266,000 | +18.2% | 442,769 | -4.4% | 0.08% | +13.4% |
| Q3 2019 | $6,147,000 | -6.6% | 462,908 | -0.9% | 0.07% | -4.3% |
| Q2 2019 | $6,583,000 | -15.2% | 467,212 | +10.7% | 0.07% | -15.7% |
| Q1 2019 | $7,767,000 | -36.2% | 422,141 | -9.3% | 0.08% | -43.5% |
| Q4 2018 | $12,165,000 | +20.0% | 465,554 | +5.4% | 0.15% | +41.3% |
| Q3 2018 | $10,140,000 | +18.3% | 441,816 | -1.8% | 0.10% | +13.0% |
| Q2 2018 | $8,573,000 | -62.4% | 450,021 | -66.7% | 0.09% | -63.8% |
| Q1 2018 | $22,791,000 | +9.3% | 1,352,576 | -1.4% | 0.25% | +15.5% |
| Q4 2017 | $20,856,000 | -11.2% | 1,372,091 | +4.6% | 0.22% | -14.7% |
| Q3 2017 | $23,491,000 | – | 1,312,334 | – | 0.26% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 4,525,476 | $74,263,000 | 4.09% |
| ARMISTICE CAPITAL, LLC | 2,828,000 | $46,407,000 | 2.68% |
| Birchview Capital, LP | 80,000 | $1,313,000 | 0.95% |
| GLOBEFLEX CAPITAL L P | 145,426 | $2,386,000 | 0.45% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 231,733 | $3,803,000 | 0.36% |
| 361 CAPITAL LLC | 77,630 | $1,274,000 | 0.35% |
| CADENCE CAPITAL MANAGEMENT LLC | 152,428 | $2,501,000 | 0.27% |
| BOOTHBAY FUND MANAGEMENT, LLC | 148,000 | $2,429,000 | 0.21% |
| EMERALD ADVISERS, LLC | 258,497 | $4,242,000 | 0.18% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 251,730 | $4,131,000 | 0.17% |